-
Study designs for identified trials in ARV-experienced, virologically suppres...
Study designs for identified trials in ARV-experienced, virologically suppressed patients. -
r37980778c78--110a43a2d3240d92d3076786107929cf
Results of key virologic endpoints from identified trials in ARV-naive patients1. -
Results of key efficacy endpoints from identified trials in ARV-experienced v...
Results of key efficacy endpoints from identified trials in ARV-experienced virologically suppressed patients. -
Results of key secondary endpoints from identified trials among ARV-naive pat...
Results of key secondary endpoints from identified trials among ARV-naive patients. -
Study designs for identified trials in ARV-naive patients.
Study designs for identified trials in ARV-naive patients. -
r37980778c78--9d9870355cd7d09c3fdd2da9a5cc63ff
Results of key secondary endpoints from identified trials among ARV-experienced HIV-suppressed patients.